Repligen's reaffirmation of its 2024 EPS guidance suggests a strong and stable financial outlook, which is likely to instill confidence in investors and potentially lead to a positive short-term impact on its stock price. The guidance aligning with consensus estimates further reinforces market expectations and the company's credibility.